Table: Hisamitsu -2016/17 group results

Hisamitsu Pharmaceutical Co

07/04/2017 07:00

Apr 7 (Reuters)-  
          Hisamitsu Pharmaceutical Co Inc  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Feb 28, 2017    Feb 29, 2016   Feb 28, 2018     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            145.93          161.85         147.00        75.80     
                 (-9.8 pct)      (+3.3 pct)     (+0.7 pct)    (+1.8 pct)  
  Operating         26.31           27.73          24.10        13.50     
                 (-5.1 pct)      (+35.1 pct)    (-8.4 pct)    (+4.9 pct)  
  Recurring         28.18           28.01          25.60        14.10     
                 (+0.6 pct)      (-1.7 pct)     (-9.2 pct)   (+12.3 pct)  
  Net 
  Net               20.40           17.78          18.50        10.40     
                 (+14.7 pct)     (-5.3 pct)     (-9.3 pct)   (+12.0 pct)  
  EPS            241.27 yen      208.81 yen     218.85 yen    123.03 yen  
  EPS Diluted    241.15 yen      208.76 yen                               
  Ann Div         81.50 yen       81.00 yen      82.00 yen                
  -Q2 Div         40.50 yen       40.00 yen      41.00 yen                
  -Q4 Div         41.00 yen       41.00 yen      41.00 yen                
   
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T 
  ((Tokyo Headline News Desk +813 6441 1812))